7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      KRCP’s past and future path

      editorial
      Kidney Research and Clinical Practice
      Korean Society of Nephrology

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Preface Kidney Research and Clinical Practice (Kidney Res Clin Pract, KRCP) is the official full-text English journal that represents the Korean Society of Nephrology (KSN), the largest professional society in Korea. KRCP has been published since 1982 and was initially published in Korean as the Korean Journal of Nephrology until 2012. To extend the scope of its readership globally, it was renamed KRCP and became an international, peer-reviewed journal published in English; its subscribers include over 10,000 current members and physicians and scientists from all over the world. KRCP has become an internationally recognized journal listed in SCOPUS, as well as in the emerging sources citation index (ESCI) in 2016. Since January 2012 [1], Professor Gheun-Ho Kim has been the Editor-in-Chief of the journal. His dedication to KRCP has been a stepping stone for the advancement and internationalization of Korean kidney disease research. On behalf of KSN members and KRCP Editorial Board Members, we would like to express our gratitude for his passion and hard work, as well as that of the previous editors. This journal has changed every 5 years, a renovation, with a new Editor-in-Chief and a new team of Deputy and Associate Editors. This issue introduces the future editorial members. I am deeply honored to be selected to be the new Editor-in-Chief of KRCP. Past Since conversion to English in 2012, KRCP has published various peer-reviewed academic papers in specialized nephrology fields quarterly both domestically and abroad. As a global kidney journal, numerous international researchers have submitted manuscripts and had them accepted after blinded review by experts and professional editing. KRCP publishes the latest knowledge on scientifically interesting topics related to nephrology. In addition, specialized topics emerging as public health concerns have been reported. In particular, pressing public health issues related to patient care have been presented to readers in a timely manner. For example, during the Middle East respiratory syndrome (MERS) outbreak in 2015, KRCP announced the MERS clinical practice guideline for hemodialysis (HD) facilities with the help of the Korean Society of Nephrology MERS-CoV Task Force Team [2]. Recently, the coronavirus disease 2019 (COVID-19) pandemic has become a public health crisis with over 21.2 million people diagnosed with the virus and 761,000 attributed deaths as of August 16, 2020. HD patients are very difficult to isolate from potential sources of infection due to the nature of dialysis treatment in a limited HD unit. COVID-19 clinical practice guidelines for HD facilities were developed by a joint committee comprised of members from the KSN, the Korean Society for Dialysis Therapy, and the Korea Disease Control and Prevention Agency. Korean clinical practice guidelines for preventing transmission of COVID-19 in HD facilities was also published in KRCP [3]. The current guidelines direct dialysis specialists and dialysis patients to recommend prevention, protection, screening, and isolation against the transmission of COVID-19 during this pandemic. Timely publishing of domestic and global health issues in KRCP expands opportunities to share academic knowledge and practical experience that will improve the care of patients both domestically and globally. An issue arising from natural disasters was also published in KRCP. Although the Korean Peninsula has been considered an earthquake-free zone, an earthquake suddenly occurred in the Gyeongju province, which was a major public health issue. In dialysis units, HD treatment was suddenly interrupted due to power failure and the need to evacuate patients for safety reasons. In that special article in a 2019 issue of KRCP, experience of the dialysis unit during a natural disaster in Gyeongju was introduced, and a plan for addressing issues related to natural disasters such as earthquakes was developed [4]. As social issues can also be published in KRCP, recent legislation (“Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life,” act no. 14013) on the suspension of life-sustaining medical care was described, and HD as a life-sustaining treatment at the end of life was discussed [5]. In addition, in cooperation with leading journals, we simultaneously published a section unifying and clarifying the nomenclature for kidney function and diseases to effectively improve global communication [6,7]. Moreover, KRCP provided a venue for the shared consensus from joint academic meetings with the Korean Diabetes Association [8,9]. Through these processes, we believe that unresolved and undisclosed scientific problems in the field of nephrology, as well as issues across different fields, can be discussed, and through this, the academic level can be raised one step further. Future KRCP’s mission during the last 5 years had been to become one of the leading journals worldwide on the topic of nephrology. These could be accomplished, in many ways, to standardize the journal format and publish the valuable manuscript given the interest of many global readers. In order to honor the tradition of KRCP and further expand it in the future, there are several important steps. In order to expand our readership base, we would like to focus on several areas. First, we seek to publish KRCP bimonthly in the near future, instead of quarterly. In addition, we will streamline the publication process to speed the time of submission and publication as much as possible. At the same time, we will make efforts to invite various reviewers for objective and accurate scientific evaluation. There are amazing new technologies to perform the basic research to nephrology field and remarkable innovation to gather and handle in the numerous clinical data. By introducing state-of-the-art research, KRCP will become one of the best journals in the nephrology field. In addition, we will try to share our knowledge by soliciting many professional reviews from experts in the field. We are deeply grateful to the previous editors and associate editors who devoted hard work and sacrifice to KRCP’s success. First, We wish to thank the previous incumbents of the Editorial Board, Prof. Gheun-Ho Kim as Editor-in-Chief, and Prof. Dae Ryong Cha, Prof. Duk-Hee Kang, Prof. Shin-Wook Kang, Prof. Yon Su Kim, Prof. Cheol Whee Park, Prof. Won Kim, and Prof. Dong-Ryeol Ryu as Associate Editors for their devotion to KRCP. I also would like to thank all previous Editorial Board Members for their hard work. We are pleased to welcome the following new Editorial Board Members: nephrologists Prof. Kyung Don Yoo, Prof. Woo Yeong Park, Prof. So-Young Lee, Prof. Soon Hyo Kwon, Prof. Jong Hyun Jhee, Prof. Jin Joo Cha, and Prof. Seon Ha Baek. KRCP has also invited Prof. Heeyeon Cho to the Editorial Board as a pediatric nephrologist, Prof. Kyung Chul Moon as a kidney pathologist, and Hyunsun Lim, Ph.D. as a statistical editor. All of the editorial members appreciate the continued interest and advice from our KRCP readers and members of the KSN, and look forward to reviewing your future research submissions. As the KRCP Editorial Committee, we seek to establish KRCP as a journal of the highest caliber in the nephrology field. Greetings on behalf of the editorial board.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities

          Coronavirus disease 2019 (COVID-19) is a highly contagious viral disease that is caused by the novel virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). COVID-19 has become pandemic since December 2019, when the first case developed in Wuhan, China. Patients receiving hemodialysis are more vulnerable to viral transmission because their immune functions are impaired and they receive treatment within a narrow space. Calling on previous experience with Middle East Respiratory Syndrome during the 2015 outbreak, the joint committee of the Korean Society of Nephrology and the Korean Society of Dialysis Therapy quickly formed a COVID-19 task force team to develop a manual before the first index case was diagnosed in the hemodialysis unit. This special article introduces clinical practice guidelines to prevent secondary transmission of COVID-19 within hemodialysis facilities, which were developed to protect patients, healthcare workers, and caregivers from this highly transmissible virus. The areas of infection control covered by these guidelines include standard precautions, performing dialysis therapy for confirmed or suspected cases, performing cohort isolation for contact patients, and disease monitoring and contact surveillance. We hope these guidelines help healthcare workers and hemodialysis patients around the world cope with the COVID-19 pandemic.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Middle East respiratory syndrome clinical practice guideline for hemodialysis facilities

            The Korean Society of Nephrology participated in the task force team consisting of government authorities and civilian experts to prevent and control the spread of Middle East respiratory syndrome (MERS) in 2015. The Korean Society of Nephrology MERS Task Force Team took an immediate action and drafted ‘the clinical recommendation for hemodialysis facilities’ to follow when the first and the only confirmed case was reported in the hemodialysis unit. Owing to the dedicated support from medical doctors, dialysis nurses, and related medical companies, we could prevent further transmission of MERS infection successfully in hemodialysis units. This special report describes the experience of infection control during MERS outbreak in 2015 and summarizes the contents of ‘the clinical practice guideline for hemodialysis facilities dealing with MERS patients’ built upon our previous experience.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement

              The safety of metformin use for patients with type 2 diabetes mellitus (T2DM) and advanced kidney disease is controversial, and more recent guidelines have suggested that metformin be used cautiously in this group until more definitive evidence concerning its safety is available. The Korean Diabetes Association and the Korean Society of Nephrology have agreed on consensus statements concerning metformin use for patients with T2DM and renal dysfunction, particularly when these patients undergo imaging studies using iodinated contrast media (ICM). Metformin can be used safely when the estimated glomerular filtration rate (eGFR) is ≥45 mL/min/1.73 m2. If the eGFR is between 30 and 44 mL/min/1.73 m2, metformin treatment should not be started. If metformin is already in use, a daily dose of ≤1,000 mg is recommended. Metformin is contraindicated when the eGFR is <30 mL/min/1.73 m2. Renal function should be evaluated prior to any ICM-related procedures. During procedures involving intravenous administration of ICM, metformin should be discontinued starting the day of the procedures and up to 48 hours post-procedures if the eGFR is <60 mL/min/1.73 m2.
                Bookmark

                Author and article information

                Journal
                Kidney Res Clin Pract
                Kidney Research and Clinical Practice
                Korean Society of Nephrology
                2211-9132
                2211-9140
                30 September 2020
                30 September 2020
                : 39
                : 3
                : 233-235
                Affiliations
                [1]Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea
                Author notes
                Correspondence: Tae-Hyun Yoo, Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea. E-mail: yoosy0316@ 123456yuhs.ac
                Author information
                https://orcid.org/0000-0002-9183-4507
                Article
                KRCP-39-233
                10.23876/j.krcp.20.158
                7530355
                32963131
                9f14b9a4-36bd-4125-9fc5-53cb3d60c79d
                Copyright © 2020 by The Korean Society of Nephrology

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 26 August 2020
                : 26 August 2020
                Categories
                Editorial

                Comments

                Comment on this article